C
Chengye Biomedical
Sustainability Report and Carbon Intensity Rankings
Is Chengye Biomedical doing their part?
Their DitchCarbon score is 30
Chengye Biomedical has a DitchCarbon Score of 30 out of 100, indicating a lower performance in sustainability measures. This score suggests that the company has a relatively high carbon intensity compared to more sustainable peers. Efforts to reduce emissions and improve sustainability practices are needed to increase their score.
This was calculated based on 30+ company specific emissions data points, the higher the score, the better. Check out our methodology.
Industry emissions intensity
Very low
Low
Medium
High
Very high
Chengye Biomedical is part of the health and social services industry, which has a low carbon intensity ranking compared to other industries. Some industries are more damaging than others, this ranking gives you an indication of how carbon intensive the industry is which this company operates in.
Location emissions intensity
Very low
Low
Unknown
High
Very high
Chengye Biomedical, located in Taiwan, operates in a region with a specific carbon intensity rating. The sustainability of the company’s operations is influenced by Taiwan’s overall carbon intensity, affecting its environmental impact.
Unlock 30+ emissions data points on Chengye Biomedical
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
Unlock 30+ emissions data points on Chengye Biomedical
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
11.56%
...this company is doing 11.56% worse in emissions than the industry average.
Chengye Biomedical, founded in 1977 and based in Taipei, operates within the health and social services industry. The company offers a comprehensive range of medical management services, including equipment collaboration, operational consulting, departmental trusteeship, and overall hospital management. Chengye Biomedical has expanded its expertise to include fields such as radiation oncology, medical imaging, neurology, surgery, ophthalmology, and the development of hospital departments, while also venturing into long-term care and advanced sterilization technologies.
Good news, Chengye Biomedical has embraced SBTi commitments
Chengye Biomedical has pledged to set science-based targets through the Science Based Targets initiative (SBTi) to reduce greenhouse gas emissions in line with climate science. This commitment means the company will develop and implement strategies to significantly cut its carbon footprint across its operations and value chain.
Participating
Claim this profile
Are you associate with this company?
Help us improve our data and claim this profile.
Our methodology
Read about our emission calculation methodologies, and what the DitchCarbon Score means.
Looking for a specific company?
Search our company directory or contact us for custom data requests.